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Objective: This study looked at a single paediatric neuro-oncology centre’s experience of 
childhood intracranial tumours seen in the ophthalmology clinic over an approximately five-
year period. This was used to analyse the role of the ophthalmologist in their long term 
follow up.  
Methods: A database was compiled of all children discussed at the neuro-oncology multi-
disciplinary team (MDT) meeting between January 2012 and April 2017. All children who 
had an intracranial tumour determined by histology or suspected on neuroimaging, who had 
also been seen in the ophthalmology clinic, were included. A retrospective case review was 
performed to create a record for each child.  
Results: The database contained 129 children of which 82 [64%] were boys and 47 [36%] 
were girls. Of these 89 [69%] had a histological diagnosis and 40 [31%] had a tumour 
suspected on neuroimaging. The most common tumour locations were the posterior fossa 
[n=54, 42%], diencephalon [n=20, 16%] and the visual pathways [n=17, 13%]. 
Papilloedema at first presentation was only found in 39 [30%] children. The most common 
other neuro-ophthalmic manifestations were non-paralytic strabismus [n=33], sixth nerve 
palsy [n=19] and seventh nerve palsy [n=12]. Non-paralytic strabismus was a presenting 
symptom in only one case. There were 13 ophthalmic surgical procedures required for these 
children, the most common being strabismus surgery. 
Conclusion: We report the types and locations of paediatric intracranial tumours seen in the 
ophthalmology clinic as well as their neuro-ophthalmic manifestations. Only 30% present 
with papilloedema and approximately 10% will require an ophthalmic surgical procedure.  
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Introduction 
Brain tumours are the most common solid tumour type1 in children whilst brain and central 
nervous system (CNS) cancers are the second leading cause of cancer death in those under 
192-4. Paediatric brain tumours are usually categorized according to histology or location5,6 
although more recently molecular parameters are also being incorporated6-9. Approximately 
50% are found in the posterior fossa with the other 50% being supratentorial10-12. Another 
key distinction is whether they are benign which corresponds roughly to the old WHO grades 
1-2 or malignant roughly corresponding to grades 3-413. These factors greatly influence the 
presenting symptoms and prognosis14,15 but also create different challenges for the 
ophthalmologist.  
The management of childhood CNS tumours is complex and is best undertaken at a paediatric 
oncology centre by a multi-disciplinary team (MDT)16,17 led by an oncologist or 
neurosurgeon14. The ophthalmologist however also plays an important role both in 
diagnosing18,19 and managing secondary abnormalities of the visual, ocular, adnexal and 
oculomotor systems of children with intracranial tumours 17,20. Whilst several studies have 
looked at the related neuro-ophthalmic manifestations21-23 in children with brain tumours, 
these have typically been performed by oncologists or neurologists24. Other studies have 
looked at the neuro-ophthalmic manifestations at presentation21,24-27 or the effect on quality of 
life28. There is however very little information in the literature regarding the neuro-
ophthalmic manifestations of these tumours managed by the ophthalmologist over time12,29 
and none, of which we are aware, reporting the ophthalmic surgical interventions required. 
Establishing exactly which neuro-ophthalmic manifestations and ophthalmic surgical 
problems are commonly encountered, demonstrates the specific skills required to manage 
these children, and helps to inform clinical planning and training requirements. This study 
therefore aims to determine the variety of paediatric brain tumours seen in the ophthalmology 
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clinic at a regional specialist referral centre as well as the neuro-ophthalmic manifestations 
encountered and which ophthalmic surgical interventions were required over an 
approximately five-year period. 
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Methods 
We compiled a database of all children who had been discussed at the neuro-oncology MDT 
meeting between January 2012 and April 2017 at our centre. The record for each child was 
then checked and included in this study, if they had a tumour proven by histology or 
suspected on neuro-imaging. In addition, they had to have been seen in the ophthalmology 
clinic at the same centre which was determined through searching the electronic patient 
records. 
This yielded 152 children, of whom 129 children had intracranial tumours and were included; 
the remainder having ocular or orbital tumours, which were excluded. A retrospective case 
review of the ophthalmology notes, clinic letters, radiology and histology reports as well as 
MDT outcomes was performed to create the record for each child. This was stored on a 
database created in Microsoft Excel and the clinical data was then analysed to determine 
relevant clinical characteristics of this cohort of patients as well as aspects relating to their 
ophthalmic management.  
In our unit a specialist orthoptist attends the MDT and coordinates the ophthalmic input 
required for each child. All children were under the care of a single paediatric 
ophthalmologist with occasional input from other subspecialties.  
This study was approved by the Research Governance and Ethics Committee of a Medical 
School Department of Postgraduate Medical Education and registered as an audit at the 
regional oncology centre where the database was compiled.  
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Results 
The cohort consisted of 129 children (82 boys [64%] and 47 girls [36%]). The mean age at 
presentation was 5.8 years (range 0-17 years) which can be seen in Figure 1. Of these 89 
[69%] had a histological diagnosis and 40 [31%] had a tumour suspected on neuro-imaging.  
The tumour type based on histology for those 89 children who had a tissue diagnosis is 
shown in Table 1. 13 children died during the follow up period all of whom had a histological 
diagnosis the breakdown of which is also shown in Table 1.   
The most common tumour location was the posterior fossa [n=54, 42%] followed by the 
diencephalon [n=20, 16%] and the visual pathways [n=17, 13%]. The full breakdown of 
tumour location is summarized in Table 2.  
At initial presentation, 39 cases [30%] were found to have papilloedema, 78 [60%] did not, 
and 12 [9%] did not have a documented optic disc assessment. During subsequent follow up, 
95 [74%] of children’s optic discs were documented as normal while 33 [26%] showed 
atrophy or pallor and 1 [1%] showed non-glaucomatous cupping. Of the 33 with atrophy or 
pallor, only 12 [36%] had previously documented papilloedema and 15 [45%] had tumours of 
the visual pathways.  
Other neuro-ophthalmic manifestations are shown in Table 3 the most common of which was 
non-paralytic strabismus [n=33] followed by sixth nerve palsy [n=19] and seventh nerve 
palsy [n=12]. Only one child presented with non-paralytic strabismus which was an exotropia 
in the context of poor vision in one eye secondary to an optic nerve glioma. One child had a 
longstanding esotropia and had previously undergone strabismus surgery. Of the remaining 
31 cases of non-paralytic strabismus observed during the period of follow up, 21 cases were 
convergent and 10 cases were divergent. Tumours located in the posterior fossa were more 
likely to lead to palsies of cranial nerves III, IV & VI [n=16, 30%] and seventh nerve palsy 
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[n=11, 20%], when compared to supratentorial tumours and palsies affecting cranial nerves 
III, IV & VI [n=8, 11%] and seventh nerve palsy [n=0, 0%]. There was one seventh nerve 
palsy in a child with tumour locations in both the posterior fossa and supratentorial region. 
All 10 cases of internuclear ophthalmoplegia were in children with tumours located in the 
posterior fossa.  
On review of the electronic patient records (but not the ophthalmology paper notes) eighty-
four cases had reliable ophthalmic data at presentation and final follow up. Of these, 14 
presented with a problem with eye movements (nystagmus, strabismus, diplopia), 26 had a 
headache, 21 had vomiting and 10 reported other visual symptoms. Fifty-four patients had a 
visual acuity of 6/9 or better at final follow up of whom 19 (35%) had neither visual or raised 
intracranial pressure symptoms at presentation. Similarly, for those children with vision 
worse than 6/9 in one eye at final follow up, 7 (27%) had neither visual or raised intracranial 
pressure symptoms at presentation. 
Thirteen ophthalmic surgical procedures were required for these children of which there were 
6 strabismus operations, 4 tarsorrhaphies, 2 cataract extractions and 1 enucleation. The 
enucleation was performed in a child with neurofibromatosis type 1 who had an intracranial 
glioma and a retinoblastoma.  
In our centre, patients were seen in the paediatric ophthalmology clinic on average 3.4 times 
in the first year after diagnosis. It is however possible that some patients could have also been 
seen in an emergency setting which would not have been captured. Those diagnosed within 
the last 5 years were then seen on average twice per year, and those diagnosed over 5 years 
ago were seen on average 0.7 times per year. In our cohort most of these children remain 
under long-term follow up, with only 9 patients discharged, all of whom were originally 
diagnosed and treated over 5 years ago. 
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Discussion 
This study looked at a particular cohort of children who had been diagnosed with intracranial 
tumours and were seen in the ophthalmology clinic at a single centre over an approximately 
five-year period. The aim of this study was to define the caseload encountered by the 
ophthalmologist working as part of the multi-disciplinary paediatric oncology team. Of 
particular interest was to determine which ophthalmic surgical procedures are required in this 
population as this has not to our knowledge been previously described. 
The distribution in terms of sex and age at presentation (Figure 1) of children with 
intracranial tumours as well as the breakdown of histological diagnosis were similar to large 
case series described by oncologists and neurosurgeons2,30,31 (Table 4). This implies that most 
children with intracranial tumours are also seen in the ophthalmology clinic. Of note, 31 
tumours [24%] in our cohort were suspected to be low grade gliomas on neuro-imaging and 
did not undergo biopsy to obtain a histological diagnosis and therefore were not included in 
this table.  
Large case series show tumour location to be roughly split with half in the posterior fossa and 
the other half supratentorial10-12. Our cohort mirrored this with 56% of tumours supratentorial 
and 42% infratentorial with 2% occurring in both locations. One difference is that the Central 
Brain Tumor Registry of the United States reported significantly fewer brainstem tumours at 
11%32. This could reflect referral bias or that there were differences in how tumour origin 
was determined with most in our cohort based on the MRI report. This is however unlikely to 
affect management by the ophthalmologist with broad distinctions between posterior fossa, 
visual pathways and supratentorial being more relevant to the neuro-ophthalmic 
manifestations that arise. Papilloedema was seen at initial presentation in only 30% of 
children which is also similar to other reports in the literature21,26 although as this was not a 
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prospective study it was not documented for all cases. Approximately half of the cases [n=20] 
were in children with tumours in the posterior fossa and half supratentorial [n=19]. Our study 
therefore highlights that a minority of children with brain tumours have papilloedema at 
presentation and therefore the absence of this sign should not delay neuro-imaging if a brain 
tumour is suspected.  
Neuro-ophthalmic manifestations of paediatric brain tumours have previously been described 
at presentation21,24,26 but there was only one study identified which looked at those that arose 
over the period of follow up in the paediatric ophthalmology clinic and consisted of 58 
cases12. Our study therefore defines the neuro-ophthalmic manifestations that are caused not 
only by these tumours but also by the surgery, chemotherapy, conventional and proton beam 
radiotherapy used to treat them. An example of this is that the two cataract extractions 
identified in our study occurred in the same patient after radiotherapy which is a common 
complication of craniospinal irradiation33. This is therefore a manifestation that would not be 
seen at presentation and would occur sometime after treatment and affect the care and 
outcome for the child and family. This highlights the importance of careful monitoring in the 
ophthalmology clinic to detect later onset complications to those seen at presentation. 
Ongoing monitoring is also important to detect visual loss and signs that may indicate 
recurrence or raised intracranial pressure29.  
Palsies of cranial nerves III, IV & VI were more common in children with tumours in the 
posterior fossa [n=16, 30%] than the supratentorial region [n=8, 11%]. 11 of the 12 seventh 
nerve palsies were in children with a tumour in the posterior fossa with one in a child with a 
tumour in both locations; all internuclear ophthalmoplegia cases were in children with 
tumours in the posterior fossa. These neuro-ophthalmic manifestations are therefore more 
commonly encountered in posterior fossa tumours whilst papilloedema was roughly equal 
between posterior fossa and supratentorial tumours.  
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We could not identify in the literature any studies which specifically looked at the types of 
ophthalmic surgical procedures required in this cohort of children. Our study demonstrates 
that a range of surgical procedures are required ranging from lid and strabismus to intraocular 
surgery. After papilloedema, non-paralytic strabismus was the most common neuro-
ophthalmic problem seen in this cohort and strabismus surgery was the most prevalent 
ophthalmic surgical procedure performed.  
Our study has all the limitations of retrospective reviews: namely reliance on existing case 
records and absence of standardization of initial assessment at presentation. Many of the 
children did not have formal orthoptic review until after their initial decompression surgery. 
Therefore it is difficult to conclude at exactly what point children developed strabismus. 
Although we report 33 patients had non-paralytic strabismus during follow up, we suspect 
that many of these patients had resolved paralytic strabismus which has been previously 
reported34. There was only one case in which a child presented with non-paralytic strabismus 
which was an exotropia in the context of very reduced vision in one eye. One child also had a 
longstanding esotropia that had previously been operated on and so was incidental.  
Unlike previous studies which have focused on neuro-ophthalmic signs at presentation we 
have aimed to define the role that the ophthalmologist plays in the long-term management of 
children with intracranial tumours. Our study suggests that the tumour types referred to the 
ophthalmology clinic broadly reflects the population of children with intracranial tumours as 
a whole, indicating there is unlikely to be a referral bias. They result in a range of neuro-
ophthalmic manifestations either from presentation or that develop later during the course of 
their treatment with papilloedema, non-paralytic strabismus and cranial nerve palsies being 
the most common.  
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We recommend that all children diagnosed with an intracranial tumour should have an 
examination of eye movements, visual acuity assessment, and optic disc assessment at 
presentation where clinically possible. Subsequently, children should be reviewed in the 
ophthalmology clinic with a full orthoptic assessment and eye examination at each visit. 
Clear recording of visual acuity in the clinic letter and electronic patient record also helps all 
those involved in their care to identify problems and trends over time. The frequency of clinic 
review depends on the risk of developing complications, such as raised intracranial pressure 
or visual loss. In our study, visual or raised intracranial pressure symptoms at presentation 
were not a predictor for visual deficit at final follow up and so each case must be assessed 
individually. Depending on location, size and histology, we recommend 3-4 monthly review 
in the first year and then 4-6 monthly to year 5 as a reasonable guide in line with the practice 
in our department.  
In conclusion the management of these children is complex and may require referral to other 
disciplines, monitoring, symptomatic management and in approximately 10% of cases, a 
range of ophthalmic surgical procedures. This demonstrates that the ophthalmologist requires 
versatility in order to provide optimum ophthalmic care to this cohort of patients as part of 
the MDT.  
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Figure legends: 
 
Figure 1: Shows the age at presentation for boys and girls 
Table 1: Breakdown by histology for all tumours and for children who died 
Table 2: Break down of tumour locations for the whole cohort 
Table 3: Frequency of neuro-ophthalmic complications in the cohort  
Table 4: Breakdown of tumours in our cohort with a histological diagnosis versus large 
cohorts taken from:  
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